Indeed, CD38 is highly up-regulated in T lymphocytes of COVID-19 acute patients (Sekine et al, 2020), and decreases over time once the infection is resolved and the inflammation state disappears (Rha et al, 2021). The gene discussed is CD38; the disease is COVID-19.